Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Harvard Business School
Healthtrust
Daiichi Sankyo
QuintilesIMS
Julphar
Moodys
Chinese Patent Office
UBS

Generated: June 21, 2018

DrugPatentWatch Database Preview

Breckenridge Pharm Company Profile

« Back to Dashboard

What is the competitive landscape for BRECKENRIDGE PHARM, and what generic and branded alternatives to BRECKENRIDGE PHARM drugs are available?

BRECKENRIDGE PHARM has thirty-two approved drugs.



Drugs and US Patents for Breckenridge Pharm

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Breckenridge Pharm OMEPRAZOLE omeprazole CAPSULE, DELAYED REL PELLETS;ORAL 203481-002 Jul 3, 2017 AB RX No No ➤ Sign Up ➤ Sign Up
Breckenridge Pharm MELOXICAM meloxicam TABLET;ORAL 077920-001 Jul 19, 2006 AB RX No No ➤ Sign Up ➤ Sign Up
Breckenridge Pharm PIOGLITAZONE HYDROCHLORIDE pioglitazone hydrochloride TABLET;ORAL 078472-002 Feb 13, 2013 AB RX No No ➤ Sign Up ➤ Sign Up
Breckenridge Pharm OMEPRAZOLE omeprazole CAPSULE, DELAYED REL PELLETS;ORAL 203481-003 Jul 3, 2017 AB RX No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for BRECKENRIDGE PHARM drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Delayed-release Tablets 20 mg ➤ Subscribe 2015-06-03
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Deloitte
Cipla
Covington
Baxter
Queensland Health
Mallinckrodt
Federal Trade Commission
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.